Search

everythinglearnresearchcommunity

for

Search:↓

Melanoma risk tools need improvement, certain gene mutations cause skin diseases and could be treated by targeting those mutations, skin wrinkling may relate to lung aging due to genetic factors, and oxidative stress affects hair loss but can be reduced in low oxygen.

The 2003 consensus updated PCOS diagnosis criteria and linked PCOS to higher risks of diabetes and heart problems, recommending lifestyle changes to lower these risks.

PCOS is a complex condition with major health impacts, needing more research for better diagnosis and treatment.

Male hormones may play a role in the development of heart disease, and more research is needed to understand their effects.

The European Society of Endocrinology advises individualized long-term management for PCOS, focusing on lifestyle changes, accurate diagnosis, and treatments for associated health risks and symptoms.

Anabolic steroids can build muscle and strength but have risks and need more research on their clinical benefits and side effects.

Insulin resistance and obesity are key factors in the development and worsening of polycystic ovary syndrome, and lifestyle changes are important for managing it.

Androgens can both increase and decrease hair growth in different parts of the body.

Androgens can help prevent memory problems caused by apoE4.

Estrogens significantly influence hair growth by interacting with receptors in hair follicles and may help regulate the hair growth cycle.

Finasteride treats enlarged prostate and hair loss, but may cause side effects in some patients.

Hormones significantly affect hair and oil gland function in the skin, and more research is needed on skin-related hormone disorders.

Acne is caused by genetics, diet, hormones, and bacteria, with treatments not yet curative.

Kennedy's disease leads to muscle weakness and sensory issues, has no cure but manageable symptoms, and future treatments look promising.

Polycystic Ovary Syndrome is linked to higher risk of hypertension and heart disease.

The TRPV3 gene mutation affects hair growth by keeping mice in the growth phase longer, which could help treat hair loss.

The document suggests that targeting the hormone DHT could be a more effective treatment for prostate cancer than targeting testosterone.

Spironolactone helps regrow hair in women with hair loss.

Chemotherapy often causes patterned hair loss, with some scalp areas more resistant to hair loss than others.

Asian hair loss differs from Europeans; consider individual needs and psychological well-being for treatment.

Current treatments for male pattern baldness include minoxidil and finasteride, with new options being developed.

Female pattern hair loss involves hormonal factors, genetics, and may be linked to low ferritin levels.

Certain HSD3B1 gene types are linked to worse prostate cancer outcomes and affect treatment response and other health conditions.

Acne is significantly influenced by genetics, and understanding its genetic basis could lead to better, targeted treatments.

The conclusion is that androgenetic alopecia and senescent alopecia have unique gene changes, suggesting different causes and potential treatments for these hair loss types.

NcoA4 may have roles beyond helping control gene activity, possibly affecting cell behavior and stability.

Androgenetic alopecia is mainly caused by genetic factors and increased androgen activity, leading to hair follicle miniaturization.

Sex hormones affect hair and feather growth and may help manage alopecia and hormone-dependent cancers.

Most hirsutism cases are due to PCOS, and treatment focuses on lowering testosterone and blocking its effects.

Hormones and genetics play key roles in male and female baldness, which can affect mental health and may be linked to other health issues.